{
    "code": "52026458",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026458",
    "time": "2019-12-20 03:56:00",
    "許可證字號": "衛部藥輸字第026458號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/11\/26",
    "發證日期": "103\/11\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202645800",
    "中文品名": "佐骨實濃縮注射液4毫克\/5毫升",
    "英文品名": "Zoldria concentrate for solution for infusion 4mg\/5ml",
    "適應症": "1.與標準癌症治療併用，適用於多發性骨髓瘤及固體腫瘤併有骨骼轉移之病人。用於攝護腺癌病人之骨骼轉移時，應至少接受過一種荷爾蒙治療而仍持續惡化者。2.治療惡性腫瘤之高血鈣併發症（HCM）。",
    "劑型": "270注射劑",
    "包裝": "5毫升塑膠瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
        "申請商名稱": "1304601100  瑞士商愛爾康大藥廠股份有限公司台灣分公司",
        "申請商地址": "新北市新店區寶中路119號4樓、5樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001630",
            "成分名稱": "ZOLEDRONIC ACID MONOHYDRATE",
            "含量描述": "(eq. to Zoledronic acid anhydrous 4mg)",
            "含量": "4.2640000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI_02026458-104-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026458&Seq=001&Type=9"
        },
        {
            "title": "52026458-104-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026458&Seq=003&Type=8"
        }
    ]
}